Takeda moves ahead in Zika race with launch of vaccine trial (via U.S.)

Japan’s Takeda Pharmaceutical has moved ahead in the race to develop a vaccine for the mosquito-borne Zika virus, with the start of a clinical trial program backed by the U.S. government.

Source: U.S.